Novartis OTC Stock Future Price Prediction

NVSEF
 Stock
  

USD 84.85  0.84  1.00%   

Novartis Ag Basl stock price prediction is an act of determining the future value of Novartis shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Novartis' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Novartis and does not consider all of the tangible or intangible factors available from Novartis' fundamental data. We analyze noise-free headlines and recent hype associated with Novartis Ag Basl, which may create opportunities for some arbitrage if properly timed.
Additionally, see Novartis Basic Forecasting Models to cross-verify your projections.
  
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Novartis based on different types of headlines from major news networks to social media. The Novartis stock price prediction module provides an analysis of price elasticity to changes in media outlook on Novartis over a specific investment horizon.
Quarterly Earnings Growth YOY
0.088
Quarterly Revenue Growth YOY
0.009
Using Novartis hype-based prediction, you can estimate the value of Novartis Ag Basl from the perspective of Novartis response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Novartis. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Novartis to buy its stock at a price that has no basis in reality. In that case, they are not buying Novartis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Novartis after-hype prediction price

    
  $ 84.85  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Novartis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Novartis in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
83.4385.0586.67
Details
Naive
Forecast
LowNext ValueHigh
86.1087.7189.33
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
78.9586.3593.75
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Novartis. Your research has to be compared to or analyzed against Novartis' peers to derive any actionable benefits. When done correctly, Novartis' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Novartis Ag Basl.

Novartis After-Hype Price Prediction Density Analysis

As far as predicting the price of Novartis at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Novartis or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Novartis, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Novartis Estimiated After-Hype Price Volatility

In the context of predicting Novartis' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Novartis' historical news coverage. Novartis' after-hype downside and upside margins for the prediction period are 83.23 and 86.47, respectively. We have considered Novartis' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 84.85
84.85
After-hype Price
86.47
Upside
Novartis is very steady asset. Analysis and calculation of next after-hype price of Novartis Ag Basl is based on 3 months time horizon.

Novartis OTC Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Novartis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Novartis backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Novartis, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.03  1.62  0.00   0.01  7 Events / Month2 Events / MonthIn about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
84.8584.850.00 
0.00  

Novartis Hype Timeline

Novartis Ag Basl is now traded for 84.85. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Novartis forecasted not to react to the next headlinewith price going to stay at about the same level and average media hype impact volatility of about 0.0%. The immediate return on the next newsis forecasted to be very small whereas the daily expected return is now at -0.03%. The volatility of relative hype elasticity to Novartis is about 415.38%. The volatility of related hype on Novartis is about 415.38% with expected price after next announcement by competition of 84.86. About 34.0% of the company shares are owned by institutional investors. The book value of Novartis was now reported as 25.38. The company next dividend is scheduled to be issued on the 8th of March 2022. Novartis Ag Basl had 40:1 split on the 7th of May 2001. Assuming the 90 days horizon the next forecastedpress releasewill be in about 7 days.
Additionally, see Novartis Basic Forecasting Models to cross-verify your projections.

Novartis Related Hype Analysis

Having access to credible news sources related to Novartis' direct competition is more important than ever and may enhance your ability to predict Novartis' future price movements. Getting to know how Novartis rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Novartis may potentially react to the hype associated with one of its peers.

Novartis Additional Predictive Modules

Most predictive techniques to examine Novartis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Novartis using various technical indicators. When you analyze Novartis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Novartis Predictive Indicators

The successful prediction of Novartis stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Novartis Ag Basl, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Novartis based on analysis of Novartis hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Novartis's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Novartis's related companies.

Story Coverage note for Novartis

The number of cover stories for Novartis depends on current market conditions and Novartis' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Novartis is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Novartis' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Novartis Short Properties

Novartis' future price predictability will typically decrease when Novartis' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Novartis Ag Basl often depends not only on the future outlook of the potential Novartis' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Novartis' indicators that are reflective of the short sentiment are summarized in the table below.
Trailing Annual Dividend Rate3.40
Float Shares2.13B
Average Daily Volume Last 10 Day29.32k
Average Daily Volume In Three Month23.92k
Trailing Annual Dividend Yield4.31%
Additionally, see Novartis Basic Forecasting Models to cross-verify your projections. Note that the Novartis Ag Basl information on this page should be used as a complementary analysis to other Novartis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Novartis OTC Stock analysis

When running Novartis Ag Basl price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.088
Market Capitalization
192.6 B
Quarterly Revenue Growth YOY
0.009
Return On Assets
0.0651
Return On Equity
0.43
The market value of Novartis Ag Basl is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine Novartis value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.